Measured by its binding ability in a functional ELISA. When Recombinant Human Lgr5/GPR49 is coated at 0.5 μg/mL, Recombinant Human TROY/TNFRSF19 binds with an apparent Kd <500 nM.
Tumor Necrosis Factor Receptor Superfamily, Member 19 | TAJ | TAJ-alpha | Toxicity and JNK inducer | TNFRSF19 | TRADE | TROY | tumor necrosis factor receptor superfamily member 19 | tumor necrosis factor receptor superfamily, member 19 | Tumor Necrosis Fa
规格或纯度
无动物源,无载体,生物活性,ActiBioPure™,His标签,≥90%(SDS-PAGE)
生物活性
Measured by its binding ability in a functional ELISA. When Recombinant Human Lgr5/GPR49 is coated at 0.5 μg/mL, Recombinant Human TROY/TNFRSF19 binds with an apparent Kd <500 nM.
Lyophilized from 10mM PBS, 5% Trehalose, 5% Mannitol, pH7.4.
复溶
Reconstitute in sterile water to a concentration of 0.1-0.5 mg/ml.
储存条件
-20°C储存,避免反复冻融
运输条件
超低温运输
稳定性与储存
在 -20~-80℃ 下可保存 1 年以上。复溶后建议分装。避免冷冻/解冻循环。
图片
Recombinant Human TROY/TNFRSF19 Protein (rp152538) - SDS-PAGE 2 μg/lane of Recombinant Human TROY/TNFRSF19 Protein was resolved with SDS-PAGE under reducing (R) and non-reducing (N) conditions and visualized by Coomassie® Blue staining, showing the band at 22 - 27 kDa due to glycosylation.
ZJ25F0927913
危险品化学品经营许可证（带存储）